机构

• 上海药物研究所 [759]
• 长春应用化学研究... [299]
• 化学研究所 [180]
• 过程工程研究所 [118]
• 大连化学物理研究所 [86]
• 上海应用物理研究所 [74]
• 更多

采集方式

• OAI收割 [2179]
• iSwitch采集 [98]

内容类型

• 期刊论文 [2243]
• 学位论文 [18]
• 会议论文 [14]
• CNKI期刊论文 [1]
• 专著 [1]

发表日期

• 2024 [80]
• 2023 [67]
• 2022 [92]
• 2021 [104]
• 2020 [115]
• 2019 [106]
• 更多

学科主题

• Pharmacol... [40]
• Chemistry [36]
• Biochemis... [25]
• Materials... [17]
• Chemistry,... [9]
• Chemistry;... [9]
• 更多

筛选

浏览/检索结果: 共2277条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序作者升序作者降序题名升序题名降序发表日期升序发表日期降序 Pharmacokinetics, mass balance, and metabolism of [14C]FCN-437c, a selective and potent CDK4/6 inhibitor in humans 期刊论文  OAI收割 CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2025, 卷号: 95, 期号: 1, 页码: 12 作者:  Gao, Lei;  Ma, Sheng;  Yan, Shu;  Zhang, Hua;  Tian, Ling   |  收藏  |  浏览/下载：19/0  |  提交时间：2025/07/25 FCN-437c  CDK4/6 inhibitor  Mass balance  Radiopharmacokinetics  Drug metabolism   Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumors 期刊论文  OAI收割 ADVANCED DRUG DELIVERY REVIEWS, 2025, 卷号: 224, 页码: 27 作者:  Zhang, Ping;  Pan, Jiaxing;  Lin, Shutong;  Peng, Bo;  An, Caiyan   |  收藏  |  浏览/下载：2/0  |  提交时间：2025/08/20 Pancreatic cancer  Cancer immune cycle  Immune resistance  Drug delivery systems  Stimuli-responsive   Guiding precision medicine strategy for intravenous ginsenosides via pharmacokinetic-informed bioinformatic approaches: a study on XueShuanTong 期刊论文  OAI收割 PHYTOMEDICINE, 2025, 卷号: 143, 页码: 18 作者:  Jia, Wei-Wei;  Tian, Nan-Nan;  Song, Zi-Jing;  Lan, Xiao-Fang;  Yang, Xi-He   |  收藏  |  浏览/下载：1/0  |  提交时间：2025/08/20 Precision medicine  Physiologically based pharmacokinetic model  Ginsenoside  Albumin-facilitated dissociation  Drug interaction  Drug transporter  Hepatic impairment   Sorafenib resistance and therapeutic strategies in hepatocellular carcinoma 期刊论文  OAI收割 BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2025, 卷号: 1880, 期号: 3, 页码: 17 作者:  Zhang, Weijing;  Hong, Xuechuan;  Xiao, Yuling;  Wang, Hongbo;  Zeng, Xiaodong   |  收藏  |  浏览/下载：17/0  |  提交时间：2025/06/23 Hepatocellular carcinoma  Sorafenib  Drug resistance  Therapeutic strategy   Advancing active compound discovery for novel drug targets: insights from AI-driven approaches 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2025, 页码: 12 作者:  Wang, Xing-you;  Chen, Yang;  Li, Yu-fan;  Wei, Chao-yang;  Liu, Meng-ya   |  收藏  |  浏览/下载：5/0  |  提交时间：2025/08/20 AI-driven drug discovery  novel drug targets  molecular design  ligand exploration  phenotypic drug discovery  undruggable targets   Risk assessment of CYP3A induction by ginsenoside's metabolites from oral Panax notoginseng (sanqi) extract 期刊论文  OAI收割 JOURNAL OF ETHNOPHARMACOLOGY, 2025, 卷号: 349, 页码: 11 作者:  Deng, Yang;  Du, Jing;  He, Xin;  Dong, Yan-Xi;  Wang, Xiao-Lei   |  收藏  |  浏览/下载：3/0  |  提交时间：2025/08/20 Panax notoginseng  Ginsenoside  Intestinal microbiota  CYP3A induction  Drug interaction   Contrastive learning-based drug screening model for GluN1/GluN3A inhibitors 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2025, 页码: 13 作者:  Li, Kun;  Zeng, Yue;  Xiong, Yi-da;  Wu, Hao-chen;  Fang, Sui   |  收藏  |  浏览/下载：3/0  |  提交时间：2025/08/20 drug-target affinity prediction  virtual screening  contrastive learning  graph neural network  N-methyl-D-aspartate (NMDA) receptors  GluN3A subunit.   Molecular basis for ligand recognition and receptor activation of the prostaglandin D2 receptor DP1 期刊论文  OAI收割 PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2025, 卷号: 122, 期号: 22, 页码: 11 作者:  Xu, Jiuyin;  Wu, Yanli;  Xu, Youwei;  Li, Yang;  He, Xinheng   |  收藏  |  浏览/下载：2/0  |  提交时间：2025/08/20 prostaglandin D2 receptor 1  receptor activation  drug design   Design, synthesis, and activity evaluation of indole derivatives as potential stabilizers for p53 Y220C 期刊论文  OAI收割 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 卷号: 121, 页码: 9 作者:  Li, Linquan;  Gu, Xi;  Meng, Jingyi;  Wen, Yiming;  Yi, Jing   |  收藏  |  浏览/下载：10/0  |  提交时间：2025/05/27 p53 Y220C  Synthesis  Structural modification  Drug design   Nanobody-based drug delivery systems for cancer therapy 期刊论文  OAI收割 JOURNAL OF CONTROLLED RELEASE, 2025, 卷号: 381, 页码: 29 作者:  Liu, Lin;  Tu, Bin;  Sun, Yao;  Liao, Lingling;  Lu, Xiaoling   |  收藏  |  浏览/下载：14/0  |  提交时间：2025/04/24 Nanobody  VHH  Cancer therapy  Targeted drug delivery systems  Nanobody modification